Results 111 to 120 of about 36,146 (282)

Current perspectives on ranibizumab

open access: yesClinical Ophthalmology, 2015
Vaidehi S Dedania,1 Sophie J Bakri21Department of Ophthalmology, Albany Medical Center, Lions Eye Institute, Albany, NY, USA; 2Department of Ophthalmology, Mayo Clinic, Rochester, MN, USABackground: This review summarizes the Phase III studies addressing
Dedania VS, Bakri SJ
doaj  

Nutritional and smoking advice recalled by patients attending a UK age-related macular degeneration clinic [PDF]

open access: yes, 2017
Background: Age-related macular degeneration (AMD) is responsible for half of registered visual impairment in the UK. The Royal College of Ophthalmologists recommends providing guidance to people with AMD regarding smoking, diet, and nutritional ...
Binns, A. M., Bott, D., Huntjens, B.
core   +1 more source

Treatment of neovascular age-related macular degeneration: Current therapies

open access: yesClinical Ophthalmology, 2009
Albert J Augustin, Stefan Scholl, Janna KirchhofDepartment of Ophthalmology, Klinikum Karlsruhe, GermanyAbstract: Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe ...
Albert J Augustin   +2 more
doaj  

Repeatability of swept-source optical coherence tomography retinal and choroidal thickness measurements in neovascular age-related macular degeneration [PDF]

open access: yes, 2017
BACKGROUND: The aim was to determine the intrasession repeatability of swept-source optical coherence tomography (SS-OCT)-derived retinal and choroidal thickness measurements in eyes with neovascular age-related macular degeneration (nAMD).
Balaggan, KS   +6 more
core  

Practical implementation of a q4–q16 aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Updated guidance from a UK expert panel [PDF]

open access: hybrid, 2022
Clare Bailey   +10 more
openalex   +1 more source

Treatment of neovascular age-related macular degeneration in patients with diabetes

open access: yesClinical Ophthalmology, 2008
Michael Cummings1, José Cunha-Vaz21Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth, UK; 2Department of Ophthalmology, University Hospital of Coimbra, Centre of Ophthalmology, Institute of Biomedical ...
Michael Cummings   +1 more
doaj  

Durability and Efficacy of Faricimab in Treatment-Resistant Retinal Edema Utilizing “Real-World” Dosing Regimens

open access: yesJournal of Ophthalmology
Conclusions: In “treatment-resistant” patients receiving anti-VEGF therapy for neovascular age-related macular degeneration or diabetic macular edema, switching to IFI in a “real-world” TAE protocol led to statistically significant improvements in ...
Shravan V. Savant   +7 more
doaj   +1 more source

Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients

open access: yesJournal of Current Ophthalmology
Purpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi   +8 more
doaj   +1 more source

In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels

open access: yesClinical Ophthalmology, 2013
Yousif Subhi, Amardeep Singh, Mads Krüger Falk, Torben Lykke SørensenDepartment of Ophthalmology, Clinical Eye Research Unit, Copenhagen University Hospital Roskilde and the University of Copenhagen, Copenhagen, DenmarkPurpose: Association of
Subhi Y   +3 more
doaj  

Home - About - Disclaimer - Privacy